tirzepatide/bpc-157 BPC-157 (Body Protection Compound) | Research Peptide Peptide of the Week: Tirzepatide,
Description
Many are familiar with research peptides
Metformin, though not a GLP-1 agonist, shares the property of reducing stomach acid and interfering with b12 absorption
Gallus can address all of it
Error 4: Giving cycle length as if it were evidence-based The "8 to 12 week cycle" convention exists because it borrows from general peptide therapy culture, not because any trial demonstrated that 12 weeks is better than 6 or that 12 weeks is the safety threshold
